Activity in the third quarter of 2016 | Bourse Reflex
Accueil > Actualités > Communiqués

Activity in the third quarter of 2016

Jeudi 20 Oct 2016 à 17:45

(Unaudited data)

  • DEVELOPMENT OF BUSINESS IN THE THIRD QUARTER (VARIATION AT CURRENT RATE)
thousands of euros 1st quarter 2nd quarter 3rd quarter
2015 2016 Var. 16/15 2015 2016 Var. 16/15 2015 2016 Var.
16/15
France 89,584 90,494 +1.0% 76,864 80,469 +4.7% 97,767 98,840 +1.1%
Europe (excluding France) 40,657 43,685 +7.4% 29,943 31,572 +5.4% 50,614 41,273 -18.5%
North America 17,193 16,064 -6.6% 12,894 14,113 +9.5% 16,055 16,020 -0.2%
Other countries 4,622 3,846 -16.8% 3,816 4,061 +6.4% 3,594 3,280 -8.7%
Group total 152,056 154,089 +1.3% 123,517 130,215 +5.4% 168,030 159,413 -5.1%

 

thousands of euros 1st quarter 2nd quarter 3rd quarter
2015 2016 Var. 16/15 2015 2016 Var. 16/15 2015 2016 Var.
16/15
Non-proprietary Homeopathic Medicines 79,191 80,147 +1.2% 74,354 76,001 +2.2% 73,677 73,913 +0.3%
OTC Specialties 72,880 73,743 +1.2% 49,030 53,719 +9.6% 94,328 85,319 -9.6%
Other -15 199 - 133 495 +272.2% 25 181 +624.0%
Group total 152,056 154,089 +1.3% 123,517 130,215 +5.4% 168,030 159,413 -5.1%
  • CUMULATIVE ACTIVITY AS OF THE END OF SEPTEMBER 2016
thousands of euros 2015 2016 Variation at current exchange rates Variation at constant exchange rates
France 264,215 269,803 +2.1% +2.1%
Europe (excluding France) 121,214 116,530 -3.9% -1.0%
North America 46,142 46,197 +0.1% +0.9%
Other countries 12,032 11,187 -7.0% -4.3%
Group total 443,603 443,717 +0.0% +1.0%

 

thousands of euros 2015 2016 Variation at current exchange rates Variation at constant exchange rates
Non-proprietary Homeopathic Medicines 227,222 230,061 +1.2% +1.3%
OTC Specialties 216,238 212,781 -1.6% +0.3%
Other 143 875 +511.9% +511.9%
Group total 443,603 443,717 +0.0% +1.0%
  • HIGHLIGHTS OF THE THIRD QUARTER
    • Sales revenue in the third quarter of 2016 was down by 5.1% in comparison to 2015 (the impact of exchange rates is not significant over the period).
    • Sales are decreasing significantly in Russia and to a lesser extent in Spain and in the Czech Republic. They are increasing in France.
  • OUTLOOK
    • The level of activity and profitability of the fiscal year will depend on the seasonal pathology of the fourth quarter.
    • Our company still continues with the same determination the development of homeopathy in the world.

Our next update: January 26, 2017 at market close, publication of the sales revenue for the year 2016.
Person responsible for FINANCIAL information: Christian Boiron
Contact for financial information: Véronique Bouscayrol
Investor relations: +33 (0) 4.78.45.63.43 - e-mail : boironfinances@boiron.fr
ISIN Code: FR0000061129 (BOI) - Bloomberg: BOI FP - Reuters: BOIR.PA
The group's financial information is online at: www.boironfinance.com



Partager sur Facebook
Article Précédent :
Activité du troisième trimestre 2016
Article Suivant :
Information Financière du 3ème...

Ecrire un commentaire

J'accepte la charte et que mon commentaire soit publié sur BourseReflex.com 

Les autres actualités


Retour vers 'Communiqués' »




Mots-clés : Euros   Thousands   Homeopathic   Rates   Sales  
Sociétés citées dans cette news : Boiron   FINANCIAL  

Si vous passez un ordre de bourse sur le CAC40 le vendredi soir à 18h, quand sera t-il éxécuté?